Purpose of review: Despite advances in targeted therapy and immunotherapy, glioblastoma (GBM) remains a therapeutic challenge because of its intrinsic adaptability, driven by intratumoural heterogeneity, cell-state plasticity, tu... ...

请注册登录后继续浏览